Alterations in the cell division:cell death ratio induce multiple autoimmune and transformation processes. Phosphoinositide 3-kinase (PI3K) controls cell division and cell death in vitro, but its effect on the function of the cellular immune system and on tumor formation in mammals is poorly characterized. Here we show that transgenic mice expressing in T lymphocytes an active form of PI3K derived from a thymic lymphoma, p65 PI3K , developed an infiltrating lymphoproliferative disorder and autoimmune renal disease with an increased number of T lymphocytes exhibiting a memory phenotype and reduced apoptosis. This pathology was strikingly similar to that described in mice exhibiting heterozygous loss of the tumor suppressor PTEN, a lipid and protein phosphatase. We show that overexpression of PTEN selectively blocks p65 PI3K -induced 3T3 fibroblast transformation. Moreover, the early development of T cell lymphomas in p65 PI3K Tg p53 ؊/؊ mice indicated that PI3K contributes to tumor development. These observations demonstrate that constitutive activation of PI3K extends T cell survival in vivo, affects T cell homeostasis, and contributes to tumor generation, supporting a model in which selective increases in one type of PTEN substrate, the PI3K-derived lipid products, induce tumorigenesis. PI3K thus emerges as a potential target in autoimmune disease and cancer therapy.-
PI3K catalyzes the formation of phosphatidylinositol (PtdIns)(3,4)P 2 and PtdIns(3,4,5)P 3 , regulating cell survival, division, and migration in vitro (reviewed in refs 1, 2). The in vivo role of 3-phosphoinositides is nonetheless poorly understood. Knockout mice for the PI3K p85␣ isoform revealed an essential role for this isoform in B cells (3, 4) . Other PI3K isoforms are retained in these mice, however, and the observation that T cell proliferation is blocked after inhibition of PI3K activity suggests that other isoforms (such as p85␤) may replace p85␣ function in T cells (3) . PI3K has also been implicated in tumor formation based on the increased copy number of 3q26, a region that includes the p110␣ catalytic subunit, in ϳ40% of ovarian tumors (5) . In addition, the tumor suppressor phosphatase PTEN, mutated in a large proportion of human tumors, down-regulates PI3K pathways (6 -8) . Nonetheless, selective impairment of 3-phosphoinositide recognition has been described in only one naturally occurring human PTEN mutation (9, 10) ; it remains unclear whether other substrates of this phosphatase, such as Shc and focal adhesion kinase (11) (12) (13) , are essential mediators of this tumor suppressor.
To elucidate PI3K involvement in T cell function and to establish the role of deregulated PI3K in tumor formation, we generated transgenic mice expressing an active PI3K form in T cells. The allele used, p65 PI3K , a truncation mutant of p85␣ isolated from a thymic lymphoma, associates with p110 and drives its constitutive activation, resulting in the induction of downstream PI3K effectors such as AKT and rac (14) . We show that expression of this active PI3K form in T lymphocytes induces cell survival in vivo, resulting in the development of an infiltrating lymphoproliferative disorder and autoimmmune renal disease similar to that developed by a heterozygous PTEN ϩ/Ϫ mice (15) . Moreover, PTEN selectively blocks PI3K-induced focus formation, but not v-src-or v-raf-induced foci. Finally, we show that p65 PI3K expression predisposes to tumor formation in vivo. Together, these results demonstrate the relevance of PI3K in T cell homeostasis and its contribution to tumor formation, and suggest that 3-phosphoinositides are the most important PTEN substrates for its tumor suppressor function.
MATERIALS AND METHODS

Mice
p65
PI3K transgenic mice (p65 PI3K Tg) were generated by inserting the HindII-NcoI fragment of p65 PI3K (14) into the BamHI site of the p56 Lck promotor (pLck) human growth hormone (hGh) vector (16) . The purified NotI fragment containing the pLck-p65 PI3K -hGH transgene was injected into the pronuclei of fertilized oocytes of (C57BL/6 ϫ CBA) F 1 mice. Microinjected eggs were transferred into pseudo-pregnant F 1 recipients. Offspring were analyzed 30 days after birth by polymerase chain reaction (PCR) and Southern blot analysis, and four transgene-positive lines were backcrossed onto the C57BL/6 background for subsequent experiments. p65 PI3K Tg mice were crossed with p53 Ϫ/Ϫ or p53 ϩ/Ϫ mice (17) to obtain the different genotype mice used in tumor formation experiments. All animals were PCR-screened using specific primers. Mice were bred and maintained under specific pathogen-free conditions at the Centro Nacional de Biotecnología.
Histology
Mice were examined twice weekly for the appearance of tumors or other clinical signs; affected mice or controls were killed, and tumor and organs were collected for histology or flow cytometry analysis. Tissues were fixed in phosphatebuffered saline (PBS) -buffered 10% formalin, processed, paraffin-embedded, and hematoxylin/eosin stained using standard techniques. For immunohistochemistry, fresh organs were included in standard tissue freezing solution (Jung, Nussloch, Germany). Frozen kidney sections were fixed with cold acetone and blocked with an avidin/biotin blocking kit (Vector, Burlingame, Calif.) for biotinylated anti-CD3 staining (145-2C11; PharMingen, San Diego, Calif.), or blocked in PBS with 10% fetal calf serum and 2% bovine serum albumin for fluorescein isothiocyanate (FITC) -conjugated goat antimouse immunoglobulin G (IgG) staining (PharMingen). Biotinylated anti-CD3-stained sections were developed with streptavidin-peroxidase (Dako, Glostrup, Denmark). Finally, sections were hematoxylin stained.
Flow cytometry, cell death analysis, and focus formation
Cell suspensions from thymus, spleen, and lymph nodes were prepared by grinding tissue through sterile wire mesh. In some assays, lymphocyte subpopulations were purified using Cellect columns (Biotex, Alberta, Canada). For cell surface staining, all antibodies (Abs) used were conjugated to FITC, phycoerythrin, or biotin. Biotinylated Abs were developed with streptavidin-SPRD (Southern Biotechnology, Birmingham, Ala.). The following Abs from PharMingen were used: CD8 (Ly-2, 53-6,7), CD4 (L3T4, H129.19), CD3 (145-2C11), CD11b (␣ chain, M1/70), B220 (CD45R, RA3-6B2), CD44 (pgp1, IM7), and CD62L (Mel-14). CD45RB (C363.16A) was from Southern Biotechnology, the annexin V-FITC kit was from Coulter Immunotech (Miami, Fla.), and labeling was performed according to manufacturer's instructions. Cells were analyzed on an EPICS XL using system II software (Coulter). DNA content estimation, in vitro culture, and anti-Fas Ab-induced cell death were performed as described (18) . Cell viability was determined by trypan blue exclusion. CD4ϩ or CD8ϩ cell number was estimated in flow cytometry analysis as the proportion of each subset at each time point. Focus formation assays were performed as described (14) . hPTEN cDNA was amplified from poly(A)-mRNA of MCF-7 cells and was subcloned in pRK5.
Biochemical and serological analyses
Cell lysis, immunoprecipitation, phospholipid in vitro kinase assays, AKT assays, and Western blotting were performed as described (14) . Anti-AKT Ab was from Upstate Biotechnology (Lake Placid, N.Y.). Anti-PTEN Ab was from Santa Cruz Biotechnology (Santa Cruz, Calif.). Serum Ig measurement was performed as described (19) . The titer represents the serum dilution yielding an A 492 equal to half-maximal binding activity of a wild-type (WT) mouse serum pool. Isotypespecific anti-dsDNA measurement and relative autoantibody unit calculation were performed as described (19) . Since WT mice have low amounts of IgG autoantibodies, autoantibody unit refers to the amount of anti-dsDNA IgG2a in a pool of p65 PI3K Tg mouse serum (100 units).
RESULTS
Generation of p65 PI3K Tg mice
Four independent Tg lines were established expressing p65 PI3K under the control of the Lck proximal promoter (16) . Two of these lines contained ten integrated copies of the transgene (high-copy founders) and two contained two integrated copies (low-copy founders). Tg females were sterile (currently under study), and transgenic lines were thus maintained by crossing Tg males onto a C57BL/6 background. High-copy founders expressed p65 PI3K in thymus at levels similar to those of endogenous p85␣ (Fig. 1A) , and were used in subsequent experiments. p65 PI3K was expressed in similar amounts in purified CD4ϩ and CD8ϩ T cells (Fig. 1B, C) , but not in purified B cells (not shown). As described in vitro (14) , p65
PI3K associates with the p110 catalytic subunit, causing increased associated lipid kinase activity ( Fig. 1D ) and activating the PI3K effector AKT (1), particularly in purified mature Tg T cells (Student's t test, Pϭ0.008; Fig. 1E ).
Peripheral CD4؉ T cell accumulation in p65
PI3K
Tg mice
Six-week-old Tg mice showed a slight increase in spleen CD4ϩ T cell number as compared to WT littermates (ϳ30% higher, PϽ0.001; Fig. 2A ); no differences were observed in CD8ϩ T cells, B lymphocytes (B220ϩ) ( Fig. 2A) , ␥␦ T cells, or natural killer cells (not shown). The increase in peripheral CD4ϩ T cells persisted in Tg mice for the following 6 -10 months. At 8 -10 months, a more marked increase in the CD4ϩ T cell pool was observed in some mice, leading to a massive accumulation of CD4ϩ T cells in 12-to 15-month-old Tg mouse spleen ( Fig. 2B ) and lymph node (not shown). Peripheral B lymphocytes (B220ϩ) and macrophages (CD11bϩ) remained essentially unchanged until 12-15 months after birth, when they also increased in Tg mice (Fig. 2B ). At this age, lymphoid organs were no longer well structured and spleens showed marked hyperplasia of the white pulp ( Fig.  2C , D; WT and Tg, respectively). In addition, these mice showed alterations such as reduced mobility and skin lesions.
Memory markers are up-regulated in CD4؉ T cells from p65 PI3K Tg mice
A hallmark of the autoimmune diseases that affect autoimmune-prone mouse strains is the progressive accumulation of activated T and B cells in the periphery. We thus compared lineage and activation marker expression in WT and p65 PI3K Tg mouse spleen and lymph node cells. The fraction of T cells expressing the shared memory/activated CD44 high CD62L low CD45RB low phenotype (20, 21) was increased in Tg mice compared to WT mice, as a function of age (not shown). Evident increases were observed in 10-month-old Tg mice (Fig. 2E ) prior to the dramatic enlargement of the T cell pool. Triple staining analysis confirmed that the CD44 high cells also expressed CD62L low and CD45RB low . To determine whether these cells represented either fully activated T lymphocytes or memory T cells, we examined expression of the specific markers of activated T lymphocytes, CD25, CD54, CD69, were immunoprecipitated with anti-p85 Ab and associated lipid kinase activity was estimated in vitro using phosphatidylinositol as substrate. E) Thymocytes or purified T cell extracts from WT and Tg mice (100 g) were immunoprecipitated with anti-AKT Ab; protein kinase activity was estimated in vitro using H2B histone as substrate. Mean cpm incorporated into H2B (four assays) is shown.
CD11b, and VLA-4 (22, 23) . Expression of these activation markers was not significantly increased in CD4ϩ T cells from p65 PI3K Tg mice between 6 wk and 10 months of age, suggesting that the CD4ϩ T cell population in these mice was enriched in memory cells. In contrast, in the CD8ϩ pool, only CD44 expression was altered (not shown). CD4ϩ memory cells accumulated as lymphoproliferative disease progressed, representing Ͼ90% of T cells at advanced stages of the disease. In some 12-to 15-month-old Tg mice, the expanding CD4ϩ cell population acquired a partially activated phenotype, with increased expression of CD69 and CD54, but not of CD25, CD11b, or VLA4. CD4ϩ T lymphocytes also showed an increase in Fas expression in mice at this age, but no significant changes were detected in CD8ϩ T lymphocytes.
Infiltrating lymphoproliferative disorder and autoimmune renal disease in adult p65
PI3K Tg mice
Serial necropsies were performed on 9 WT and 29 Tg mice showing signs of disease at ages ranging from 12 to 15 months. Transgenic mice showed large lymphoid infiltrates in nonlymphoid organs including lung, salivary glands, kidney, ovary, and at advanced disease stages in liver, heart, gastrointestinal tract, and pancreas. In lung, the organ with the heaviest mononuclear accumulation, infiltrates were typically perivascular, with penetration of the vascular wall, showing no signs of parenchymal destruction ( Fig. 3A, B ; WT and Tg, respectively). Flow cytometric analysis of lung cell suspensions showed that the mononuclear infiltrate was composed primarily of CD4ϩ T cells (60%; the remainder were CD8ϩT cells, B cells and, in a lower proportion, macrophages). p65 PI3K Tg mouse kidneys also showed heavy cellular infiltrates (Fig. 3C) , apparently enriched in T cells (Fig. 3D) , as well as glomerulonephritis in severely affected animals (see below). The remaining organs also showed lymphocyte infiltration, with no signs of tissue destruction. Flow cytometry analysis of T cell receptor V␤ chain expression in 10 affected Tg mice indicated that the lymphocytic expansion was polyclonal (not shown).
The appearance of glomerulonephritis in animals with severe lymphoproliferative disorder suggested immune complex-mediated autoimmunity. Most 12-to 15-month-old p65 PI3K Tg mice showed polyclonal hypergammaglobulinemia (Fig. 4A) , with marked increases in IgG1 (ϳ50-fold) and moderate increases in IgG2a (ϳ10-fold). Anti-double-stranded DNA autoantibodies (dsDNA Ab) were also elevated in the serum of most Tg mice; these were mainly of the IgG1 (10-to 1000-fold increase) and IgG2a isotypes (10-fold increase) (Fig. 4B ). IgG1 production is driven by Th1 cytokines (IL-4) (24) and, in accordance with the pronounced increase in IgG1 dsDNA Ab, a large proportion of 12-to 15-month-old Tg mice exhibited increased serum interleukin 4 (IL-4) levels (not shown). Histological comparison of WT and p65 PI3K Tg kidneys (Fig. 4C , D, respectively) showed severe mesangioproliferative glomerulonephritis in Tg mice, with an increase in mesangial matrix, thickened capillary walls, and obliteration of many capillaries. p65 PI3K Tg mouse kidneys showed granular immune complexes in immunohistological examination (Fig. 4E ) similar to those observed in MLR-lpr mice (Fig. 4F ), which were absent in WT controls. In conclusion, the majority of animals with advanced lymphoproliferative disease also developed severe autoimmune glomerulonephritis.
The p65 PI3K transgene increases T cell survival
Expansion of the CD4ϩ lymphocyte pool in Tg mice suggested that p65 PI3K augmented cell survival and/or division rates. To study this, freshly isolated CD4ϩ and CD8ϩ cells from young (6-wk-old) WT and Tg mice were labeled with annexin V (25) to measure the in vivo cell death rate. Annexin V labeling was lower in CD4ϩ cells from Tg mice than in WT controls (not shown). These differences were more pronounced in Tg mouse CD4ϩ memory cells (Fig. 5A) , as CD4ϩCD44 high cells showed significantly lower annexin V labeling than did WT controls (Pϭ0.008). No differences were observed between WT and Tg mice in the CD4ϩCD44 low/int pools, which stained for annexin V at low levels, or in the CD8ϩ cell subpopulations. The expanding CD4ϩ memory cell population in Tg mice thus exhibits defective cell death in vivo. Similar results were obtained when memory cells were selected according to CD4ϩCD62L low expression. We next examined spontaneous in vitro cell death rates, which consistently showed greater CD4ϩ Tg splenocyte viability compared to CD4ϩ WT cells (Pϭ0.006; Fig. 5B ). The percentage of apoptotic CD4ϩ cells in Tg splenocyte cultures was significantly lower than for WT mice (Fig. 5C) . Transgenic CD4ϩ cells also showed decreased activation-and Fas-induced cell death compared to WT mice (10 to 20% lower, not shown). In vitro activation of T cells with suboptimal doses of anti-CD3-TcR antibody yielded only moderately increased proliferation rates in Tg T cells compared to WT cells (not shown), possibly the consequence of the increased Tg CD4ϩ cell survival. In vivo BrdU labeling (20, 21) showed a similar proportion of dividing T cells in WT and Tg mice both in the CD4ϩ (15-16% CD4ϩBrdU high ) and the CD8ϩ cell pool (12-13% CD8ϩBrdU high ). These results thus provide evidence that in vivo PI3K activation induces cell survival and appears to contribute to the increased generation and/or persistence of memory cells.
PTEN tumor suppressor inhibits p65
PI3K -induced focus formation
The pathology developed by p65 PI3K Tg mice was strikingly similar to that described in a PTEN ϩ/Ϫ mouse model (15) . This suggests that 3-phosphoinositides, rather than PTEN protein substrates, give rise to the lymphoproliferative and autoimmune disorder in PTEN ϩ/Ϫ mice. We previously showed that p65
PI3K cooperates with v-raf to trigger focus formation in 3T3 cells (14) . To analyze whether PTEN also counteracts the action of PI3K in cell transformation, we examined the ability of PTEN to inhibit p65 PI3K -induced 3T3 cell transformation. Here we show that ectopic expression of PTEN inhibits focus formation by p65 PI3K alone or in combination with v-raf, but does not affect foci induced by v-raf alone or by v-src (Fig. 6A) ; partial inhibition was observed in v-ras-induced foci (not shown). Analysis of a fraction of the transfected samples used in focus formation assays showed that PTEN expression was two-to fourfold higher than that of the endogenous enzyme (Fig. 6B) , and was capable of inhibiting AKT induction by p65 PI3K (not shown). Similar results were observed using another constitutive active PI3K mutant (26), p110-CAAX (not shown), demonstrating that recombinant PTEN selectively counteracts cell transformation mediated by constitutively active PI3K.
p65
PI3K involvement in tumor development
Of the three available murine heterozygous loss mutants for PTEN, one develops lymphoproliferative/autoimmune disease; the other two PTEN ϩ/Ϫ models exhibit lymph node hyperplasia (27) and a moderate predisposition to develop lymphomas, which increases when secondary mutations are introduced by irradiation (27, 28) . For efficient in vitro 3T3 cell transformation, p65 PI3K also requires cooperation with other oncogenes. In vivo, p65 PI3K gave rise to the described premalignant lymphoproliferative disease. To evaluate whether p65 PI3K cooperates with other pathways to induce tumor formation in vivo, we crossed p65 PI3K Tg mice with p53 Ϫ/Ϫ mice (17) and examined offspring for tumors. Whereas 46% of p53 Ϫ/Ϫ mice were alive at 5 months of age, all p65 PI3K Tg p53 Ϫ/Ϫ mice had died by this age (Fig.  7A) . In addition, p53 Ϫ/Ϫ littermates developed lymphomas (67%) and sarcomas (33%) whereas p65
PI3K
Tg p53
Ϫ/Ϫ mice developed only lymphomas (Fig.  7B) , which affected primarily the thymus (Fig. 7C) . The phenotype of the thymic lymphomas was similar in both mice except for CD3 high expression (Fig.  7D) , which was found in a larger proportion of p65 PI3K Tg p53 Ϫ/Ϫ thymic lymphomas. Some of these p65 PI3K Tg p53 Ϫ/Ϫ thymic lymphomas also affected secondary lymphoid organs, particularly those in which cells expressed CD3 high . T cell receptor V␤ expression analysis of CD3ϩ lymphomas demonstrated the clonal nature of these tumors (not shown). All p53 ϩ/Ϫ mice analyzed were viable for Figure 6 . PTEN inhibits p65 PI3K -induced focus formation. A) 3T3 cells (2ϫ10 5 ) were transfected with pSG5 empty vector (4 g); with pSG5-p65 PI3K (1.5 g) alone or in the presence of pSG5-PTEN (1 g); or LXV3⌬raf (1.5 g) alone or in the presence of pRK5-PTEN (1 g); or pSG5-p65 PI3K (1.5 g) plus LXV3⌬raf (1.5 g) alone or in the presence of pRK5-PTEN (1 g or 2 g, indicated with an asterisk), and focus formation was monitored. We also transfected 3T3 cells with pEF-BOS-v-src (50 ng) alone or with pRK5-PTEN (2 g) to examine focus formation. B) Cells transfected as in panel A were lysed 24 h after transfection; lysates were resolved in 8%-SDS-PAGE (50 g) and PTEN was expression examined in Western blot. the first 6 months after birth, whereas viability was lower (80%) in p65 PI3K Tg p53 ϩ/Ϫ mice, with death caused by generalized lymphomas. These results show that expression of p65 PI3K in T lymphocytes results in greater predisposition to tumor development, cooperating with defects in the tumor suppressor p53, to generate T cell lymphomas.
DISCUSSION
Transgenic mice expressing an active form of phosphoinositide 3-kinase (p65 PI3K ) in T cells were generated to study the involvement of PI3K in T cell function in vivo and its role in tumor formation. These animals showed prolonged CD4ϩ T cell survival and developed an infiltrating lymphoproliferative disorder as well as autoimmune disease, with increased numbers of memory T lymphocytes. These observations indicate an essential role for PI3K in control of T cell homeostasis. In addition, we show that p65
PI3K expression predisposes to in vivo tumor formation via a pathway apparently distinct from that of p53, but similar to that of PTEN.
Adult p65 PI3K Tg mice showed a dramatic increase in activated/memory CD4ϩ T lymphocytes, indicating that T cells are highly sensitive to an increase in PI3K-derived lipid products. The T cell sensitivity to this active PI3K form suggests that PI3K activation by the IL-2 growth factor receptor, described in in vitro cell systems (18, 29, 30) , may also induce in vivo T cell survival. In addition to the lymphoproliferative disease, p65 PI3K Tg mice had elevated serum immunoglobulin and autoantibody levels that led to autoimmune renal disease. A similar process occurs in human systemic lupus erythematosus (SLE), as well as in murine SLE models (MLR-lpr and MLR-gld) (31) . In these mice, disease develops with age, resulting in an enlarged T cell population and autoantibody production; disease development is associated with defective apoptosis (32) . Similarly, cell death defects appear to cause the lymphoproliferative disorder in p65 PI3K Tg mice. The increased PI3K activity p65 PI3K Tg mice affected cell death in CD4ϩ but not CD8ϩ T cells, indicating differential sensitivity of distinct T cell populations to PI3K activation. Of the CD4ϩ cells, only memory T cells showed in vivo cell death defects. This may explain the limited CD4ϩ T cell expansion in young p65 PI3K Tg mice, when the memory compartment is small, and disease development in older mice, when large numbers of memory cells have been generated (20, 21) .
The lower activation requirements of memory cells (23) may also facilitate their induction and, in turn, B cell activation at the onset of autoimmune renal disease. Of the two mechanisms by which autoreactive T cells cause autoimmunity, direct participation of autoreactive T cells in tissue destruction or secondary activation of B cells (31) , T cells in p65 PI3K Tg mice appear to induce autoimmunity by activating B cells. The multiorgan T lymphocyte infiltration in p65 PI3K Tg mice was remarkable, matched only by that observed in CTLA4 Ϫ/Ϫ mice (33, 34) and in PTEN ϩ/Ϫ mice (15); these latter animals exhibit a pathology very similar to that in the p65 PI3K Tg mice (see below). All of these mice exhibit autoimmune disease, but whereas the actively dividing activated T lymphocytes of CTLA4 Ϫ/Ϫ mice cause multiorgan tissue destruction, the memory population of T lymphocytes in p65 PI3K Tg mice provoke no obvious tissue destruction (under study) except for the induction of B cell-mediated glomerulonephritis. In p65 PI3K Tg mice, T cell infiltration may be enhanced by PI3K involvement in integrin-induced migration, as has been suggested based on in vitro models (35) .
Comparison of the p65 PI3K Tg mouse phenotype with that of one of the PTEN ϩ/Ϫ mouse models (15) showed that both animals undergo remarkably similar lymphoproliferative and autoimmune disease processes. The lymphoproliferative disorder in p65 PI3K Tg mice is due to an alteration in the T cell compartment to which transgene expression is restricted, suggesting that T cells may also be essential in triggering the lymphoproliferative/autoimmune disease in PTEN ϩ/Ϫ mice. The earlier development of the pathological process in PTEN ϩ/Ϫ mice as compared to p65 PI3K Tg mice may be due the generalized genetic defect (in T and B cells) in the former animals (15) . Lymphoproliferative disease was found in only one of the three PTEN ϩ/Ϫ mouse models (15) ; the other two models are predisposed to hyperproliferative lymphoid disorders such as lymph node hyperplasia (27) and T cell lymphomagenesis, particularly after irradiation (27, 28) . All these mice also showed variably increased transformation susceptibility in other tissues (27, 28, 36) . The differences among these three models suggest that, as in murine SLE models (31), the distinct genetic background contributes to determining disease development. The alterations in other cell types were not observed in p65 PI3K Tg mice, as the transgene is expressed only in T cells. Nevertheless, the fact that PI3K activation in p65 PI3K Tg mice causes such a similar pathology to that developed in one of the PTEN ϩ/Ϫ mouse models suggests that, of the different PTEN substrates (11-13), 3-phosphoinositides are responsible for inducing the lymphoproliferative/autoimmune disease.
The observation that PTEN inhibited p65 PI3K -induced focus formation, but not v-raf-or v-src-induced foci, constitutes clear evidence that PTEN suppresses tumor formation via PI3K pathways. Finally, the earlier development of T cell lymphomas in p65 PI3K 
Tg p53
Ϫ/Ϫ mice shows that activation of PI3K pre-disposes to tumor formation and that this pathway cooperates with genetic defects in p53. Together, our results demonstrate the essential role of PI3K-derived lipid products in increasing cell survival in vivo, in regulation of lymphocyte homeostasis, and in tumor generation. This supports a model in which increased levels of only one PTEN substrate, the 3-phosphoinositides, induce transformation.
